Prognosis and Tumor-Infiltrating Lymphocytes (tils) in Estrogen Receptor (Er)-Low Metastatic Breast Cancer (MBC): Analysis from a Large Multi-Institutional Cohort and the TONIC Phase II Trial with Nivolumab.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined